These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 29194123)

  • 1. Anti-HIV-1 antibody-dependent cellular cytotoxicity: is there more to antibodies than neutralization?
    Lee WS; Kent SJ
    Curr Opin HIV AIDS; 2018 Mar; 13(2):160-166. PubMed ID: 29194123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies.
    von Bredow B; Arias JF; Heyer LN; Moldt B; Le K; Robinson JE; Zolla-Pazner S; Burton DR; Evans DT
    J Virol; 2016 Jul; 90(13):6127-6139. PubMed ID: 27122574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of ADCC Breadth of Human Nonneutralizing Anti-HIV-1 Antibodies.
    Bruel T; Guivel-Benhassine F; Lorin V; Lortat-Jacob H; Baleux F; Bourdic K; Noël N; Lambotte O; Mouquet H; Schwartz O
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28122982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond Viral Neutralization.
    Lewis GK; Pazgier M; Evans DT; Ferrari G; Bournazos S; Parsons MS; Bernard NF; Finzi A
    AIDS Res Hum Retroviruses; 2017 Aug; 33(8):760-764. PubMed ID: 28084796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-specific CD4-induced Antibodies Mediate Broad and Potent Antibody-dependent Cellular Cytotoxicity Activity and Are Commonly Detected in Plasma From HIV-infected humans.
    Williams KL; Cortez V; Dingens AS; Gach JS; Rainwater S; Weis JF; Chen X; Spearman P; Forthal DN; Overbaugh J
    EBioMedicine; 2015 Oct; 2(10):1464-77. PubMed ID: 26629541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects.
    Dupuy FP; Kant S; Barbé A; Routy JP; Bruneau J; Lebouché B; Tremblay C; Pazgier M; Finzi A; Bernard NF
    mBio; 2019 Dec; 10(6):. PubMed ID: 31848282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis.
    Duchemin M; Khamassi M; Xu L; Tudor D; Bomsel M
    Front Immunol; 2018; 9():244. PubMed ID: 29651286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent
    Bardhi A; Wu Y; Chen W; Li W; Zhu Z; Zheng JH; Wong H; Jeng E; Jones J; Ochsenbauer C; Kappes JC; Dimitrov DS; Ying T; Goldstein H
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
    Cheeseman HM; Olejniczak NJ; Rogers PM; Evans AB; King DFL; Ziprin P; Liao HX; Haynes BF; Shattock RJ
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells.
    Cohen YZ; Lorenzi JCC; Seaman MS; Nogueira L; Schoofs T; Krassnig L; Butler A; Millard K; Fitzsimons T; Daniell X; Dizon JP; Shimeliovich I; Montefiori DC; Caskey M; Nussenzweig MC
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies.
    Richardson SI; Chung AW; Natarajan H; Mabvakure B; Mkhize NN; Garrett N; Abdool Karim S; Moore PL; Ackerman ME; Alter G; Morris L
    PLoS Pathog; 2018 Apr; 14(4):e1006987. PubMed ID: 29630668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 Reservoir.
    Mujib S; Liu J; Rahman AKMN; Schwartz JA; Bonner P; Yue FY; Ostrowski MA
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Ability of Plant-Derived PGT121 Glycovariants To Eliminate HIV-1-Infected Cells.
    Anand SP; Ding S; Tolbert WD; Prévost J; Richard J; Gil HM; Gendron-Lepage G; Cheung WF; Wang H; Pastora R; Saxena H; Wakarchuk W; Medjahed H; Wines BD; Hogarth M; Shaw GM; Martin MA; Burton DR; Hangartner L; Evans DT; Pazgier M; Cossar D; McLean MD; Finzi A
    J Virol; 2021 Aug; 95(18):e0079621. PubMed ID: 34232070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Harnessing Antibody-Dependent Cellular Cytotoxicity To Control HIV-1 Infection.
    Abuharfeil NM; Yaseen MM; Alsheyab FM
    ACS Infect Dis; 2019 Feb; 5(2):158-176. PubMed ID: 30525453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Fc-Mediated Antibody Functions Against HIV-1 Beyond Neutralization.
    Su B; Dispinseri S; Iannone V; Zhang T; Wu H; Carapito R; Bahram S; Scarlatti G; Moog C
    Front Immunol; 2019; 10():2968. PubMed ID: 31921207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Qualitative and quantitative variables that affect the potency of Fc- mediated effector function in vitro and in vivo: considerations for passive immunization using non-neutralizing antibodies.
    Lewis GK
    Curr HIV Res; 2013 Jul; 11(5):354-64. PubMed ID: 24191940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short Communication: Small-Molecule CD4 Mimetics Sensitize HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity by Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Nonhuman Primates.
    Ding S; Verly MM; Princiotto A; Melillo B; Moody AM; Bradley T; Easterhoff D; Roger M; Hahn BH; Madani N; Smith AB; Haynes BF; Sodroski J; Finzi A
    AIDS Res Hum Retroviruses; 2017 May; 33(5):428-431. PubMed ID: 27846736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADCC-mediating non-neutralizing antibodies can exert immune pressure in early HIV-1 infection.
    Mielke D; Bandawe G; Zheng J; Jones J; Abrahams MR; Bekker V; Ochsenbauer C; Garrett N; Abdool Karim S; Moore PL; Morris L; Montefiori D; Anthony C; Ferrari G; Williamson C
    PLoS Pathog; 2021 Nov; 17(11):e1010046. PubMed ID: 34788337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancing Virion Tethering by BST2 Sensitizes Productively and Latently HIV-infected T cells to ADCC Mediated by Broadly Neutralizing Antibodies.
    Pham TN; Lukhele S; Dallaire F; Perron G; Cohen ÉA
    Sci Rep; 2016 Nov; 6():37225. PubMed ID: 27853288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells.
    Fisher L; Zinter M; Stanfield-Oakley S; Carpp LN; Edwards RW; Denny T; Moodie Z; Laher F; Bekker LG; McElrath MJ; Gilbert PB; Corey L; Tomaras G; Pollara J; Ferrari G
    Front Immunol; 2019; 10():2741. PubMed ID: 31827470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.